China Endocrinology Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Endocrinology drugs are drugs used to regulate the endocrine system and balance the endocrine system.

    A healthy human body regulates the metabolism and physiological functions of the human body through various hormones in the endocrine system and the nervous system. Disturbance of homeostasis for some reason (for example, too much or too little of a certain hormone), will cause endocrine disorders and cause corresponding clinical manifestations. Endocrine disorders can affect people's health, and in severe cases, they can cause some complications.

    Due to the rising incidence of endocrine diseases, the global endocrinology drugs market is expected to achieve considerable growth during the forecast period. Unhealthy lifestyles and excessive work pressure eventually lead to failure of the endocrine system, which promotes the growth of the endocrinology drugs market.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Endocrinology Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Endocrinology Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Endocrinology Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Merck

    • Bayer

    • AstraZeneca

    • GSK

    • Novo Nordisk

    • Eli Lily

    • AbbVie

    • Sanofi

    • Astellas Pharma

    By Type:

    • Thyroid hormone disorder drugs

    • Diabetes drugs

    • Human growth hormone

    • Testosterone replacement therapy

    By End-User:

    • Drugstore

    • Hospital

    • Clinics

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Endocrinology Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Endocrinology Drugs Market Size and Growth Rate of Thyroid hormone disorder drugs from 2016 to 2027

    • 1.3.2 China Endocrinology Drugs Market Size and Growth Rate of Diabetes drugs from 2016 to 2027

    • 1.3.3 China Endocrinology Drugs Market Size and Growth Rate of Human growth hormone from 2016 to 2027

    • 1.3.4 China Endocrinology Drugs Market Size and Growth Rate of Testosterone replacement therapy from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Endocrinology Drugs Market Size and Growth Rate of Drugstore from 2016 to 2027

    • 1.4.2 China Endocrinology Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.3 China Endocrinology Drugs Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.4 China Endocrinology Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Endocrinology Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Endocrinology Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Thyroid hormone disorder drugs

    • 3.4.2 Market Size and Growth Rate of Diabetes drugs

    • 3.4.3 Market Size and Growth Rate of Human growth hormone

    • 3.4.4 Market Size and Growth Rate of Testosterone replacement therapy

    4 Segmentation of Endocrinology Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Endocrinology Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Endocrinology Drugs in Drugstore

    • 4.4.2 Market Size and Growth Rate of Endocrinology Drugs in Hospital

    • 4.4.3 Market Size and Growth Rate of Endocrinology Drugs in Clinics

    • 4.4.4 Market Size and Growth Rate of Endocrinology Drugs in Others

    5 Market Analysis by Regions

    • 5.1 China Endocrinology Drugs Production Analysis by Regions

    • 5.2 China Endocrinology Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Endocrinology Drugs Landscape Analysis

    • 6.1 North China Endocrinology Drugs Landscape Analysis by Major Types

    • 6.2 North China Endocrinology Drugs Landscape Analysis by Major End-Users

    7 Central China Endocrinology Drugs Landscape Analysis

    • 7.1 Central China Endocrinology Drugs Landscape Analysis by Major Types

    • 7.2 Central China Endocrinology Drugs Landscape Analysis by Major End-Users

    8 South China Endocrinology Drugs Landscape Analysis

    • 8.1 South China Endocrinology Drugs Landscape Analysis by Major Types

    • 8.2 South China Endocrinology Drugs Landscape Analysis by Major End-Users

    9 East China Endocrinology Drugs Landscape Analysis

    • 9.1 East China Endocrinology Drugs Landscape Analysis by Major Types

    • 9.2 East China Endocrinology Drugs Landscape Analysis by Major End-Users

    10 Northeast China Endocrinology Drugs Landscape Analysis

    • 10.1 Northeast China Endocrinology Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Endocrinology Drugs Landscape Analysis by Major End-Users

    11 Southwest China Endocrinology Drugs Landscape Analysis

    • 11.1 Southwest China Endocrinology Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Endocrinology Drugs Landscape Analysis by Major End-Users

    12 Northwest China Endocrinology Drugs Landscape Analysis

    • 12.1 Northwest China Endocrinology Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Endocrinology Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Merck

      • 13.1.1 Merck Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bayer

      • 13.2.1 Bayer Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 AstraZeneca

      • 13.3.1 AstraZeneca Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 GSK

      • 13.4.1 GSK Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novo Nordisk

      • 13.5.1 Novo Nordisk Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Eli Lily

      • 13.6.1 Eli Lily Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 AbbVie

      • 13.7.1 AbbVie Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Sanofi

      • 13.8.1 Sanofi Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Astellas Pharma

      • 13.9.1 Astellas Pharma Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Thyroid hormone disorder drugs from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Diabetes drugs from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Human growth hormone from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Testosterone replacement therapy from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Drugstore from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Endocrinology Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Endocrinology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Endocrinology Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Endocrinology Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Endocrinology Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Endocrinology Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Thyroid hormone disorder drugs

    • Figure Market Size and Growth Rate of Diabetes drugs

    • Figure Market Size and Growth Rate of Human growth hormone

    • Figure Market Size and Growth Rate of Testosterone replacement therapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Endocrinology Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Endocrinology Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Drugstore

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Table China Endocrinology Drugs Production by Regions

    • Table China Endocrinology Drugs Production Share by Regions

    • Figure China Endocrinology Drugs Production Share by Regions in 2016

    • Figure China Endocrinology Drugs Production Share by Regions in 2021

    • Figure China Endocrinology Drugs Production Share by Regions in 2027

    • Table China Endocrinology Drugs Consumption by Regions

    • Table China Endocrinology Drugs Consumption Share by Regions

    • Figure China Endocrinology Drugs Consumption Share by Regions in 2016

    • Figure China Endocrinology Drugs Consumption Share by Regions in 2021

    • Figure China Endocrinology Drugs Consumption Share by Regions in 2027

    • Table North China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table North China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure North China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure North China Endocrinology Drugs Consumption Share by Types in 2027

    • Table North China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure North China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure North China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table Central China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table Central China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure Central China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure Central China Endocrinology Drugs Consumption Share by Types in 2027

    • Table Central China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure Central China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure Central China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table South China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table South China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure South China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure South China Endocrinology Drugs Consumption Share by Types in 2027

    • Table South China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure South China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure South China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table East China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table East China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure East China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure East China Endocrinology Drugs Consumption Share by Types in 2027

    • Table East China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure East China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure East China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure Northeast China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure Northeast China Endocrinology Drugs Consumption Share by Types in 2027

    • Table Northeast China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure Southwest China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure Southwest China Endocrinology Drugs Consumption Share by Types in 2027

    • Table Southwest China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Endocrinology Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Endocrinology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Endocrinology Drugs Consumption Share by Types in 2016

    • Figure Northwest China Endocrinology Drugs Consumption Share by Types in 2021

    • Figure Northwest China Endocrinology Drugs Consumption Share by Types in 2027

    • Table Northwest China Endocrinology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Endocrinology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Endocrinology Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Endocrinology Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Endocrinology Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Eli Lily

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily

    • Figure Sales and Growth Rate Analysis of Eli Lily

    • Figure Revenue and Market Share Analysis of Eli Lily

    • Table Product and Service Introduction of Eli Lily

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.